| abstract |
The present disclosure relates to a novel small molecule CD73 inhibitor, a preparation method therefor and a pharmaceutical use thereof. Particularly, the present disclosure relates to a small molecule CD73 inhibitor represented by general formula (I), a preparation method therefor, a pharmaceutical composition containing the derivative, and use thereof as a therapeutic agent, particularly in the preparation of a medicament for treating CD73-mediated diseases and conditions. The substituents of general formula (I) are as defined in description. |